In thyroid nodules with no aggressive features, GEA was most commonly associated with the HRAS mutation (n = 12, 34.3%), NRAS mutation (n = 10, 28.6%), and CNA (n = 8, 22.8%). Here, HRAS is linked to thyroid nodule.